MAPK3 and osteosarcoma: To examine the relevance of the PLA2G16 and ERK1/2 phosphorylation in primary patient samples, an osteosarcoma tissue array was generated including thirty-five (39.8%) female and 53 (60.2%) male patients with histologically confirmed osteosarcoma.